Non‐<scp>H</scp>odgkin lymphoma subtype distribution, geodemographic patterns, and survival in the <scp>US</scp>: A longitudinal analysis of the <scp>N</scp>ational <scp>C</scp>ancer <scp>D</scp>ata <scp>B</scp>ase from 1998 to 2011
Mohammed Al‐Hamadani(Gundersen Health System), Ronald S. Go(Mayo Clinic), Thomas M. Habermann(Mayo Clinic), William R. Macon(Mayo Clinic), Matthew J. Maurer(Boston University), James R. Cerhan(Mayo Clinic)
Cited by 280
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k
2016 US lymphoid malignancy statistics by World Health Organization subtypes
|CA A Cancer Journal for Clinicians|2016|1.1k
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
|Nature Medicine|2015|1.1k